SuperworthSiga Technologies market cap SIGA
Share price times shares outstanding: what the whole company sells for, since 2011.
- Today, Oct 23, 2026
- $224.2M
- Highest close in our data
- $1.8B
- Aug 2022
Siga Technologies is worth $224.2M at the close on Oct 23, 2026, at $3.12 a share.
That is down 63% over the last year and down 59% over five years.
Its highest close in our data was $1.8B in Aug 2022.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $224.2M | $215.5M | $486.2M | −50% |
| 2025 | $449M | $385M | $655.9M | +6% |
| 2024 | $423.4M | $331.3M | $748.7M | +6% |
| 2023 | $398.1M | $317.7M | $614.9M | −26% |
| 2022 | $537.5M | $455.1M | $1.8B | −4% |
| 2021 | $557.4M | $434.3M | $686.3M | −1% |
| 2020 | $562.7M | $357.6M | $600M | +45% |
| 2019 | $387.7M | $358.6M | $618.5M | −35% |
| 2018 | $595.2M | $376.4M | $653.1M | +56% |
| 2017 | $382.7M | $159.6M | $392.2M | +145% |
| 2016 | $156.3M | $23.3M | $176.4M | +588% |
| 2015 | $22.7M | $16.5M | $131.6M | −71% |
| 2014 | $78.7M | $69M | $196.1M | −55% |
| 2013 | $176M | $142M | $223.6M | +31% |
| 2012 | $134.8M | $122.9M | $192.8M | +4% |
| 2011 | $129.6M | $98.2M | $297.1M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Siga Technologies' size, closest first, today.
| Company | Market cap |
|---|---|
| SIGASiga Technologies | $224.2M |
| NATRNatures Sunshine Products | $213.8M |
| ARVNArvinas | $477.3M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| LFVNLifevantage | $73.4M |
| COLLCollegium Pharmaceutical | $747.5M |
| SPROSpero Therapeutics | $64.6M |
| ABUSArbutus Biopharma | $831M |
| Peer median | $570.3M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Siga Technologies
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.